Blood Testing Product Applications

Pathological waste is basically the by-product from operations and other types of surgery. Incineration is still the recognised way to safely dispose of all kinds of pathological ...

By Inciner8 Limited based in Southport, UNITED KINGDOM.

The diagnosis of heart failure typically starts when a patient talks to their caregiver about the signs and symptoms they are experiencing. Their health care provider may ask questions designed to confirm the causes of heart failure that may be in their medical history as ...

By Impulse Dynamics based in Marlton, NEW JERSEY (USA).

Similarly, laboratory blood tests for specific immunoglobulin E (sIgE) levels have a long turnaround time until results, thus delaying treatment up to several days and requiring multiple visits. ...

By Abionic SA based in Epalinges, SWITZERLAND.

ATIVA’s rapid low-cost COVID-19 test may provide earlier detection and a safer community. The greatest challenge we face is the spread of infection before symptoms appear. ...

By Ativa Medical based in Shoreview, MINNESOTA (USA).

The Ankle Brachial Index is a standard and common method of physiologic assessment of vascular pathology in the lower limbs in a fast and simple ...

By Viasonix based in Ra’anana, ISRAEL.

In the Primary Care segment, blood and urine tests drive nearly 70% of Physician decisions, guiding nearly two-thirds of healthcare ...

By Ativa Medical based in Shoreview, MINNESOTA (USA).

Non-small cell lung cancer (NSCLC) is not a single disease, but a collection of cancer types whose pathology is classified by histology (cells) and molecular profiling (genetic and protein ...

By Biocept based in San Diego, CALIFORNIA (USA).

You need a complete answer to provide the best ...

By Biocept based in San Diego, CALIFORNIA (USA).

A NEW WAY TO POWER YOUR DECENTRALIZED CLINICAL TRIALS; Unlock the power of anytime, anywhere blood testing for your program. Tasso Solutions streamline the deployment and execution of at-home testing for ...

By Tasso, Inc. based in Seattle, WASHINGTON (USA).

A liquid biopsy from Biocept gives you a new tool for profiling breast cancer—with a simple blood ...

By Biocept based in San Diego, CALIFORNIA (USA).

We are collaborating with leading hospitals, integrated health systems, medical centers and biobanks around the world to conduct studies in order to further develop and validate UDX's blood test for early cancer ...

By Universal Diagnostics SL based in Seville, SPAIN.

Medica has redefined blood gas analysis, allowing blood tests for critically ill and emergency patients to be performed rapidly and accurately. ...

By Medica Corporation based in Bedford, MASSACHUSETTS (USA).

Peripheral Arterial Disease (PAD) is a growing public health issue affecting 202 million people worldwide.1 It is an obstruction of the blood flow in the peripheral arteries, most commonly to the lower limbs and ...

By QT Vascular Ltd. based in , SINGAPORE.

Whole blood testing in low volume clinics without incurring high capital costs for large ...

By Proxim Diagnostics Corp. based in Santa Clara, CALIFORNIA (USA).

The future of Continuous Glucose Monitoring (CGM) is here ...

By Senseonics based in Germantown, MARYLAND (USA).

Type 1 diabetes is a common chronic disease, affecting millions of people throughout the world, in which the immune system attacks the body’s own pancreatic cells, stopping the production of insulin. Though it was previously considered a childhood disease, type 1 diabetes is known to affect people at every age, and it has no ...

By Eli Lilly and Company based in Indianapolis, INDIANA (USA).

Lower extremity Segmental Blood Pressures (SBP) diagnosis refers to the measurement of the systolic blood pressure at various sites along each ...

By Viasonix based in Ra’anana, ISRAEL.

Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...

By Biocept based in San Diego, CALIFORNIA (USA).